Headline: New Analysis Suggests Long-Term Effectiveness for Wegovy Users
Caption:
NBC reports that patients taking Novo Nordisk's obesity treatment maintain an average of 10% weight loss over four years. The news potentially boosts the drugmaker's push for Wegovy to be covered by insurers and governments.